Discovering Novel Antimicrobials
Dr. Dao Nguyen received funding from MI4 for her grant “Discovering Novel Antimicrobials from the Canadian High Arctic”
News
Respiratory Research News from the Meakins-Christie Laboratories and the RESP program of the RI-MUHC. View our latest funding results, faculty and trainee awards, and our research featured in the media.
Health Matters: Microbiome and TB Elimination in Quebec
MUHC Foundation Health Matters interview Irah King about our microbiome and Kevin Schwartzman about eliminating TB
World TB Day 2022
On World TB Day 2022, read about some of the work being done by RI-MUHC researchers that progress towards the WHO goal of a world free of TB.
BCG vaccine provides protection against influenza virus but not SARS-CoV-2
Maziar Divangahi and his research team are surprised to discover that BCG provides protection against respiratory infections but not SARS-CoV-2.
Health Matters: Excellence in respiratory care and research
MUHC Foundation’s Health Matters discusses excellence in respiratory research and care with respiratory specialists at the Montreal Chest Institute
International Rare Disease Day: Alex’s Story
At the Meakins-Christie Laboratories, we care about rare diseases. Read Alexandre Grant’s interview on his rare disease diagnosis.
Health Matters: Bringing awareness to rare diseases
Arnold Kristof, MD, speaks with Tarah Schwartz on an MUHC Foundation’s Health Matters podcast, discussing LAM and other rare diseases, and his hopes for future research in this area.
Breathing Easier after COVID
Read how one patient’s journey post-COVID has led him to co-chair the the Dream Big: Breathe Easier campaign.
Muscular dystrophy and trained immunity
Basil Petrof, MD, and his research team, have uncovered a new mechanism of inflammation in muscular dystrophy, paving the way for the development of new therapies.
McGill medical cannabis experts teach in Malta
Carolyn Baglole dispel myths about cannabis use in medicine as part of McGill Medical Cannabis Course